Cargando…

Evolving measles status and immunization policy development in six European countries

Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifti...

Descripción completa

Detalles Bibliográficos
Autores principales: Vojtek, Ivo, Larson, Heidi, Plotkin, Stanley, Van Damme, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009904/
https://www.ncbi.nlm.nih.gov/pubmed/35180372
http://dx.doi.org/10.1080/21645515.2022.2031776
_version_ 1784687364366401536
author Vojtek, Ivo
Larson, Heidi
Plotkin, Stanley
Van Damme, Pierre
author_facet Vojtek, Ivo
Larson, Heidi
Plotkin, Stanley
Van Damme, Pierre
author_sort Vojtek, Ivo
collection PubMed
description Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifting measles epidemiology in six European countries (Italy, Belgium, Germany, Romania, UK, and Ukraine); where policies and strategies have evolved in response to country-specific disease and vaccination patterns. Periodic outbreaks have occurred in all countries against a background of declining measles-containing-vaccine (MCV) uptake and increasing public vaccine hesitancy (with substantial regional or social differences in measles burden and vaccine uptake). Health-care worker (HCW) vaccine skepticism is also seen. While many outbreaks arise or involve specific susceptible populations (e.g., minority/migrant communities), the broader pattern is spread to the wider (and generally older) population; often among incompletely/non-vaccinated individuals as a legacy of previous low uptake. Immunization policy and strategic responses are influenced by political and social factors, where public mistrust contributes to vaccine hesitancy. A strong centralized immunization framework (allied with effective regional implementation and coherent political commitment) can effectively increase uptake. Mandatory vaccination has increased childhood MCV uptake in Italy, and similar benefits could be anticipated for other countries considering vaccine mandates. Although possible elsewhere, socio-political considerations render mandating impractical in other countries, where targeted immunization activities to bolster routine uptake are more important. Addressing HCW skepticism, knowledge gaps, improving access and increasing public/community engagement and education to address vaccine hesitancy/mistrust (especially in communities with specific unmet needs) is critical.
format Online
Article
Text
id pubmed-9009904
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-90099042022-04-15 Evolving measles status and immunization policy development in six European countries Vojtek, Ivo Larson, Heidi Plotkin, Stanley Van Damme, Pierre Hum Vaccin Immunother Licensed Vaccines – Research Paper Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifting measles epidemiology in six European countries (Italy, Belgium, Germany, Romania, UK, and Ukraine); where policies and strategies have evolved in response to country-specific disease and vaccination patterns. Periodic outbreaks have occurred in all countries against a background of declining measles-containing-vaccine (MCV) uptake and increasing public vaccine hesitancy (with substantial regional or social differences in measles burden and vaccine uptake). Health-care worker (HCW) vaccine skepticism is also seen. While many outbreaks arise or involve specific susceptible populations (e.g., minority/migrant communities), the broader pattern is spread to the wider (and generally older) population; often among incompletely/non-vaccinated individuals as a legacy of previous low uptake. Immunization policy and strategic responses are influenced by political and social factors, where public mistrust contributes to vaccine hesitancy. A strong centralized immunization framework (allied with effective regional implementation and coherent political commitment) can effectively increase uptake. Mandatory vaccination has increased childhood MCV uptake in Italy, and similar benefits could be anticipated for other countries considering vaccine mandates. Although possible elsewhere, socio-political considerations render mandating impractical in other countries, where targeted immunization activities to bolster routine uptake are more important. Addressing HCW skepticism, knowledge gaps, improving access and increasing public/community engagement and education to address vaccine hesitancy/mistrust (especially in communities with specific unmet needs) is critical. Taylor & Francis 2022-02-18 /pmc/articles/PMC9009904/ /pubmed/35180372 http://dx.doi.org/10.1080/21645515.2022.2031776 Text en © 2022 GlaxoSmithKline Biologicals S.A. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Licensed Vaccines – Research Paper
Vojtek, Ivo
Larson, Heidi
Plotkin, Stanley
Van Damme, Pierre
Evolving measles status and immunization policy development in six European countries
title Evolving measles status and immunization policy development in six European countries
title_full Evolving measles status and immunization policy development in six European countries
title_fullStr Evolving measles status and immunization policy development in six European countries
title_full_unstemmed Evolving measles status and immunization policy development in six European countries
title_short Evolving measles status and immunization policy development in six European countries
title_sort evolving measles status and immunization policy development in six european countries
topic Licensed Vaccines – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009904/
https://www.ncbi.nlm.nih.gov/pubmed/35180372
http://dx.doi.org/10.1080/21645515.2022.2031776
work_keys_str_mv AT vojtekivo evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries
AT larsonheidi evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries
AT plotkinstanley evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries
AT vandammepierre evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries